Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Acadia Pharmaceuticals buy Robert W. Baird

Start price
€15.02
09.05.24 / 50%
Target price
€26.02
09.05.25
Performance (%)
14.12%
Price
€17.14
25.07.24
Summary
This prediction is currently active. The BUY prediction by Robert_W__Baird currently has a performance of 14.12%. This prediction currently runs until 09.05.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Acadia Pharmaceuticals 3.817% 3.817%
iShares Core DAX® 0.039% 0.567%
iShares Nasdaq 100 -4.018% -5.554%
iShares Nikkei 225® -2.389% -1.434%
iShares S&P 500 -2.115% -2.351%

Comments by Robert_W__Baird for this prediction

In the thread Acadia Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 14.12%
Target price 26.020
Change
Ends at 09.05.25

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Robert W. Baird from $31.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for ACAD provided by MarketBeat